THERIAC LIMITED

Company Registration Number:
10375051 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2024

Period of accounts

Start date: 01 October 2023

End date: 30 September 2024

THERIAC LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2024

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

THERIAC LIMITED

Company Information

for the Period Ended 30 September 2024




Registered office: Vsm Pharmacy
124 Frimley Road
Camberley
England
GU15 2QN
Company Registration Number: 10375051 (England and Wales)

THERIAC LIMITED

Balance sheet

As at 30 September 2024


2024
£

2023
£
Called up share capital not paid: 0 0
Fixed Assets: 1,684 4,191
Current assets: 330,103 315,415
Creditors: amounts falling due within one year: ( 30,581 ) ( 57,901 )
Net current assets (liabilities): 299,522 257,514
Total assets less current liabilities: 301,206 261,705
Total net assets (liabilities): 301,206 261,705
Capital and reserves: 301,206 261,705

THERIAC LIMITED

Balance sheet continued

For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 12 March 2025
And Signed On Behalf Of The Board By:

Name: Thierry Thielens
Status: Director

The notes form part of these financial statements

THERIAC LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 September 2024

  • 1. Employee Information

    Average number of employees: 1

THERIAC LIMITED

Footnotes to the Financial Statements

for the Period Ended 30 September 2024

  • 2. Off balance sheet disclosure

    No